BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC)

Historical Holders from Q2 2019 to Q3 2025

Symbol
BCYC on Nasdaq
Type / Class
Equity / Common Stock, par value $0.004 per share ("Shares")
Shares outstanding
22,866,677
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
36,906,185
Holdings value
$285,619,779
% of all portfolios
0.001%
Number of holders
99
Number of buys
48
Number of sells
-44
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Forbion Growth Opportunities Fund II Cooperatief U.A. 7.3% $28,343,629 3,452,330 Forbion Growth Opportunities Fund II Cooperatief U.A. 21 Nov 2024
WESTFIELD CAPITAL MANAGEMENT CO LP 5.49% $21,430,867 2,610,337 Westfield Capital Management Company, L.P. 31 Dec 2024
ARMISTICE CAPITAL, LLC 9.99% $18,275,048 2,284,381 Armistice Capital, LLC 30 Jun 2025
Point72 Asset Management, L.P. 3.9% -48.8% $14,882,536 -$15,032,008 1,860,317 -50.2% Point72 Asset Management, L.P. 30 Jun 2025
Deep Track Capital, LP 2.42% -54.2% $9,625,952 -$12,943,416 1,203,244 -57.3% Deep Track Capital, LP 30 Jun 2025

Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 36,906,185 $285,619,779 -$29,768,237 $7.74 99
2025 Q2 41,200,406 $286,338,478 -$7,404,258 $6.95 110
2025 Q1 41,735,285 $354,350,748 -$8,366,393 $8.49 95
2024 Q4 41,890,221 $586,472,317 -$21,543,705 $14 96
2024 Q3 40,439,351 $915,266,321 +$21,080,974 $22.63 104
2024 Q2 39,722,044 $803,959,492 +$167,237,644 $20.24 105
2024 Q1 30,475,266 $758,677,656 +$6,974,793 $24.9 93
2023 Q4 31,374,408 $567,252,558 -$28,664,876 $18.08 98
2023 Q3 32,418,922 $651,281,538 +$165,201,151 $20.09 101
2023 Q2 24,236,173 $618,449,426 +$18,484,148 $25.52 84
2023 Q1 23,558,818 $498,895,905 -$47,151,037 $21.27 89
2022 Q4 23,577,228 $697,847,861 +$39,624,167 $29.6 87
2022 Q3 23,196,999 $539,598,338 +$13,911,506 $23.26 77
2022 Q2 22,709,672 $381,075,755 -$69,885,312 $16.78 78
2022 Q1 20,168,148 $884,247,452 -$137,175,184 $43.88 100
2021 Q4 21,550,279 $1,311,636,981 +$387,558,387 $60.87 98
2021 Q3 14,210,499 $591,072,741 +$80,484,868 $41.59 67
2021 Q2 12,412,613 $376,901,461 +$30,169,498 $30.36 53
2021 Q1 11,420,830 $341,203,000 +$123,064,104 $29.87 39
2020 Q4 7,328,435 $131,544,000 -$3,975,466 $17.95 27
2020 Q3 7,550,163 $143,830,000 +$24,085,212 $19.05 18
2020 Q2 6,287,737 $98,861,000 +$4,298,929 $15.74 15
2020 Q1 5,977,254 $81,901,000 +$1,078,206 $13.65 12
2019 Q4 5,901,993 $55,657,000 -$6,870,216 $9.43 8
2019 Q3 6,446,149 $73,420,000 -$1,907,302 $11.39 11
2019 Q2 6,635,216 $66,751,000 +$66,751,000 $10.06 14